Sign in
4/A

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001359820-12-000009

CEO bought 10,500 shares at an average $0.54 ($5,655)

From the SEC's structured data for this filing

Trades in this filing

Babcock Dwight William · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2012-02-17 Purchase : show line 1 in the form +10,000 $0.54 $5,400 195,873 D
2012-02-21 Purchase : show line 2 in the form +500 $0.51 $255 196,373 D
Open-market purchases · 10,500 sh · avg $0.54 · $5,655
Loading xslF345X03/primary_doc.xml…